HCA Healthcare, Inc. (HCA)

Basic

  • Market Cap

    $82.52B

  • EV

    $126.19B

  • Shares Out

    264.5M

  • Revenue

    $64.97B

  • Employees

    265,000

Margins

  • Gross

    39.37%

  • EBITDA

    19.55%

  • Operating

    14.82%

  • Pre-Tax

    11.86%

  • Net

    8.07%

  • FCF

    7.21%

Returns (5Yr Avg)

  • ROA

    10.97%

  • ROTA

    1,206.26%

  • ROE

    459.64%

  • ROCE

    21.65%

  • ROIC

    17.11%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $330.47

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,022M

  • Net Debt

    $40.84B

  • Debt/Equity

    39.49

  • EBIT/Interest

    4.97

Growth (CAGR)

  • Rev 3Yr

    8.03%

  • Rev 5Yr

    6.84%

  • Rev 10Yr

    6.63%

  • Dil EPS 3Yr

    20.18%

  • Dil EPS 5Yr

    12.22%

  • Dil EPS 10Yr

    18.86%

  • Rev Fwd 2Yr

    5.77%

  • EBITDA Fwd 2Yr

    4.74%

  • EPS Fwd 2Yr

    9.64%

  • EPS LT Growth Est

    9.47%

Dividends

  • Yield

  • Payout

    12.47%

  • DPS

    $2.4

  • DPS Growth 3Yr

    77.38%

  • DPS Growth 5Yr

    11.38%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    5.65%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

51,336

51,533

58,752

60,233

64,968

Total Revenues % Chg.

10%

0.4%

14%

2.5%

7.9%

Cost of Goods Sold, Total

32,041

32,243

36,260

37,056

39,389

Gross Profit

19,295

19,290

22,492

23,177

25,579

Selling General & Admin Expenses, Total

855

923

989

976

994

Depreciation & Amortization

2,596

2,721

2,853

2,969

3,077

Other Operating Expenses

8,626

8,384

8,972

10,179

11,881

Other Operating Expenses, Total

12,077

12,028

12,814

14,124

15,952

Operating Income

7,218

7,262

9,678

9,053

9,627

Interest Expense, Total

-1,824

-1,584

-1,566

-1,741

-1,938

Net Interest Expenses

-1,824

-1,584

-1,566

-1,741

-1,938

Income (Loss) On Equity Invest.

43

54

113

45

22

EBT, Excl. Unusual Items

5,437

5,732

8,225

7,357

7,711

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

18

-7

1,620

1,301

-5

Legal Settlements

Other Unusual Items

-211

-295

-12

-78

EBT, Incl. Unusual Items

5,244

5,430

9,833

8,580

7,706

Income Tax Expense

1,099

1,043

2,112

1,746

1,615

Earnings From Continuing Operations

4,145

4,387

7,721

6,834

6,091

Minority Interest

-640

-633

-765

-1,191

-849

Net Income

3,505

3,754

6,956

5,643

5,242

Net Income to Common Incl Extra Items

3,505

3,754

6,956

5,643

5,242

Net Income to Common Excl. Extra Items

3,505

3,754

6,956

5,643

5,242

Total Shares Outstanding

338.4

339.4

305.5

277.4

265.5

Weighted Avg. Shares Outstanding

341.2

338.3

323.3

290.3

272.4

Weighted Avg. Shares Outstanding Dil

348.2

343.6

328.8

294.7

276.4

EPS

10.3

11.1

21.5

19.4

19.2

EPS Diluted

10.1

10.9

21.2

19.2

19

EBITDA

9,814

9,983

12,531

12,022

12,704